Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons
- 1 April 1995
- journal article
- Published by Elsevier in Neuroscience
- Vol. 65 (4) , 1041-1050
- https://doi.org/10.1016/0306-4522(94)00537-f
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Fos Immunoreactivity after Stimulation or Inhibition of Muscarinic Receptors Indicates Anatomical Specificity for Cholinergic Control of Striatal Efferent Neurons and Cortical Neurons in the RatEuropean Journal of Neuroscience, 1993
- Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assayMolecular Brain Research, 1992
- Striatal c‐fos Induction by Cocaine or Apomorphine Occurs Preferentially in Output Neurons Projecting to the Substantia Nigra in the RatEuropean Journal of Neuroscience, 1992
- D1 Dopamine Receptor Activation of Multiple Transcription Factor Genes in Rat StriatumJournal of Neurochemistry, 1992
- Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: A quantitative in situ hybridization studyNeuroscience, 1991
- Molecular cloning and expression of the gene for a human D1 dopamine receptorNature, 1990
- D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neuronsNeuroscience, 1990
- Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter.Molecular and Cellular Biology, 1989
- Morphine activation of c-fos expression in rat brainBiochemical and Biophysical Research Communications, 1988
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977